Cannabis ingredient holds promise as antipsychotic medicine

Cannabis ingredient holds promise as antipsychotic medicine

Kate Kelland | December 15, 2017

Scientists conducted a small trial of people with psychosis and found patients treated with CBD had lower levels of psychotic symptoms than those who received a placebo. Psychosis is characterized by paranoia and hallucinations.

The study found that they were also more likely to be rated as “improved” by their psychiatrist and there were signs of better cognitive performance and functioning.

Cannabis ingredient holds promise as antipsychotic medicine






Comments are Closed